---
title: PolyPeptide Group vs Sinopep-Allsino Biopharmaceutical Co., Ltd.
slug_a: polypeptide
slug_b: sinopep
site: cdmo
review_signal_gate: closed
canonical_path: /compare/polypeptide/sinopep
generated_by: BioBM Editorial AI
---

# PolyPeptide Group vs Sinopep-Allsino Biopharmaceutical Co., Ltd.

This comparison is auto-generated by BioBM Editorial AI and intended as an evidence-oriented side-by-side reference.

## Company A

PolyPeptide Group (polypeptide) is listed for cdmo. Specialized global CDMO for peptide-based active pharmaceutical ingredients, supporting development and manufacturing of proprietary and generic APIs with expertise in peptide synthesis and GMP manufacturing.

Services: 7. Modalities: 1. Indications: 1. Locations: 1. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (7).

Review summary: Review summary withheld until site-level review gate opens.

## Company B

Sinopep-Allsino Biopharmaceutical Co., Ltd. (sinopep) is listed for cdmo. GMP peptide and oligonucleotide CDMO offering custom synthesis, NCE development, CMC manufacturing, and finished dosage form formulation services for therapeutic programs.

Services: 6. Modalities: 2. Indications: 0. Locations: 0. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (6).

Review summary: Review summary withheld until site-level review gate opens.